Thursday, July 23, 2020 3:02:52 PM
Pfizer Analyst Says COVID-19-Driven Rally
Not Backed By Vaccine Economics $PFE https://benzinga.com/z/16752732#.XxnegL3y3Fc.twitter… via
@benzinga
https://www.benzinga.com/analyst-ratings/analyst-color/20/07/16752732/pfizer-analyst-says-covid-19-driven-rally-not-backed-by-vaccine-economics
Not Backed By Vaccine Economics $PFE https://benzinga.com/z/16752732#.XxnegL3y3Fc.twitter… via
@benzinga
https://www.benzinga.com/analyst-ratings/analyst-color/20/07/16752732/pfizer-analyst-says-covid-19-driven-rally-not-backed-by-vaccine-economics
Recent PFE News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:39:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:37:54 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 04/27/2026 10:23:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:22:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:22:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 10:22:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 09:16:36 PM
- Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company • Business Wire • 04/24/2026 10:59:00 AM
- Pfizer Declares Second-Quarter 2026 Dividend • Business Wire • 04/22/2026 08:45:00 PM
- Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 • Business Wire • 04/21/2026 03:51:00 PM
- U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility • PR Newswire (US) • 04/20/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 05:16:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 08:31:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 05:10:35 PM
- Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders • Business Wire • 04/09/2026 02:00:00 PM
- Telix Strengthens Board with Additional Director Appointments • GlobeNewswire Inc. • 04/08/2026 10:44:20 PM
- AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:52:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:22:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:21:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:20:23 AM
